All three classes of CpG ODNs up-regulate IP-10 gene in pigs

Research in Veterinary Science

Volumn 88, Issue 2, 2010, Pages 242-250

  Dar, Arshud ^a   Nichani, Anil ^b   Lai, Ken ^a   Potter, Andy ^a   Gerdts, Volker ^a   Babiuk, Lorne A ^c   Mutwiri, George ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

CpG oligodeoxynucleotide; Cytokines; Gene expression; Innate immune response; Porcine PBMC; qRT PCR

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SWINE; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL10; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; SWINE; UP-REGULATION;

ANIMALIA; SUIDAE; SUS;

EID: 76849090972     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.10.003     Document Type: Article

References (70)

1. Abel K., Wang Y., Fritts L., Sanchez E., Chung E., Fitzgerald-Bocarsly P., Krieg A.M., and Miller C.J. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells. Clin. Diagn. Lab. Immunol. 12 (2005) 606-621
2. Bauer S., and Wagner H. Bacterial CpG-DNA licenses TLR9. Curr. Top. Microbiol. Immunol. 270 (2002) 145-154
3. Blackwell S.E., and Krieg A.M. CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. J. Immunol. 170 (2003) 4061-4068
4. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematsu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T., and Akira S. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201 (2005) 19-25
5. Coico R. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protocols Immunol. 2 (1996) 7.1.1
6. Cooper C.L., Ahluwalia N.K., Efler S.M., Vollmer J., Krieg A.M., and Davis H.L. Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers. J. Immune Based Ther. Vac. 6 (2008) 3
7. Dar A., Nichani A.K., Benjamin P., Lai K., Soita H., Krieg A.M., Potter A., Babiuk L.A., and Mutwiri G.K. Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression. Vet. Immunol. Immunopathol. 123 (2008) 324-336
8. Deng J.C., Moore T.A., Newstead M.W., Zeng X., Krieg A.M., and Standiford T.J. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J. Immunol. 173 (2004) 5148-5155
9. Domeika K., Magnusson M., Eloranta M.L., Fuxler L., Alm G.V., and Fossum C. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet. Immunol. Immunopathol. 101 (2004) 87-102
10. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., and Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162 (1999) 2291-2298
11. Flaminio M.J., Borges A.S., Nydam D.V., Horohov D.W., Hecker R., and Matychak M.B. The effect of CpG-ODN on antigen presenting cells of the foal. J. Immune Based Ther. Vac. 5 (2007) 1
12. Gupta K., and Cooper C. A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases. Drugs R D 9 (2008) 137-145
13. Gursel M., Verthelyi D., Gursel I., Ishii K.J., and Klinman D.M. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71 (2002) 813-820
14. Harandi A.M., Eriksson K., and Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77 (2003) 953-962
15. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., and Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33 (2003) 1633-1641
16. Hartmann G., and Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164 (2000) 944-953
17. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., and Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164 (2000) 1617-1624
18. Hayashi M., Kuwahara M., Ogata M., Miyao-Kurosaki N., Abel T., Ueki R., Yano M., Fujii M., Hartmann G., and Takaku H. Evaluating the immune responses stimulated by CpG oligodeoxynucleotides. Nucleic Acids Res. Suppl. 323 (2003) 4
19. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
20. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
21. Jurk M., Schulte B., Kritzler A., Noll B., Uhlmann E., Wader T., Schetter C., Krieg A.M., and Vollmer J. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 209 (2004) 141-154
22. Kamstrup S., Frimann T.H., and Barfoed A.M. Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides. Antivir. Res. 72 (2006) 42-48
23. Kamstrup S., Verthelyi D., and Klinman D.M. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet. Microbiol. 78 (2001) 353-362
24. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., and Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170 (2003) 4465-4474
25. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249-258
26. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93 (1996) 2879-2883
27. Kranzer K., Bauer M., Lipford G.B., Heeg K., Wagner H., and Lang R. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology 99 (2000) 170-178
28. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
29. Krieg A.M., Efler S.M., Wittpoth M., Al Adhami M.J., and Davis H.L. Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J. Immunother. 27 (2004) 460-471
30. Krieg A.M., Love-Homan L., Yi A.K., and Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161 (1998) 2428-2434
31. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., and Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
32. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., and Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001) 2154-2163
33. Krug A., Rothenfusser S., Selinger S., Bock C., Kerkmann M., Battiany J., Sarris A., Giese T., Speiser D., Endres S., and Hartmann G. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells. J. Immunol. 170 (2003) 3468-3477
34. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., and Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31 (2001) 3026-3037
35. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., and Golenbock D.T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5 (2004) 190-198
36. Li J., Gao R., Wu M., Meng M., Tang M., Shen Y., Wang L., Wu X., Yin X., Xie H., and Liu S. The immunoregulation of mice by somatic transgenic expression of porcine interleukin-6 gene and CpG sequence. Vet. Res. Commun. 28 (2004) 33-46
37. Linghua Z., Xingshan T., and Fengzhen Z. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Vet. Immunol. Immunopathol. 115 (2007) 216-222
38. Linghua Z., Yong G., Xingshan T., and Fengzhen Z. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Dev. Comp. Immunol. 30 (2006) 589-596
39. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
40. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., Coffman R.L., and Van Nest G. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73 (2003) 781-792
41. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat. Immunol. 8 (2007) 11-13
42. Medzhitov R. CpG DNA: security code for host defense. Nat. Immunol. 2 (2001) 15-16
43. Murphy K.M., Ouyang W., Farrar J.D., Yang J., Ranganath S., Asnagli H., Afkarian M., and Murphy T.L. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18 (2000) 451-494
44. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., den Hurk S., Mena A., Tsang C., Alcon V., Nichani A., Ioannou X., Gomis S., Townsend H., Hecker R., Potter A., and Babiuk L.A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 91 (2003) 89-103
45. Mutwiri G.K., Nichani A.K., Babiuk S., and Babiuk L.A. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J. Control Release 97 (2004) 1-17
46. Nguyen K.B., Watford W.T., Salomon R., Hofmann S.R., Pien G.C., Morinobu A., Gadina M., O'Shea J.J., and Biron C.A. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297 (2002) 2063-2066
47. Nichani A.K., Dar M.A., Krieg A.M., Mirakhur K.K., Kaushik R.S., Griebel P.J., Manuja A., Townsend H.G., Babiuk L.A., and Mutwiri G.K. Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep. Vet. Immunol. Immunopathol. 115 (2007) 357-368
48. Nichani A.K., Kaushik R.S., Mena A., Popowych Y., Dent D., Townsend H.G., Mutwiri G., Hecker R., Babiuk L.A., and Griebel P.J. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep. Cell. Immunol. 227 (2004) 24-37
49. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., Townsend H.G., Hecker R., Krieg A.M., Babiuk L.A., and Griebel P.J. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding. Oligonucleotides 16 (2006) 58-67
50. Nichani A.K., Mena A., Popowych Y., Dent D., Townsend H.G., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P.J. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet. Immunol. Immunopathol. 98 (2004) 17-29
51. Olbrich A.R., Schimmer S., Heeg K., Schepers K., Schumacher T.N., and Dittmer U. Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs. J. Virol. 76 (2002) 11397-11404
52. Pasparakis M., Alexopoulou L., Episkopou V., and Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice. A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184 (1996) 1397-1411
53. Pfeffer L.M., Dinarello C.A., Herberman R.B., Williams B.R., Borden E.C., Bordens R., Walter M.R., Nagabhushan T.L., Trotta P.P., and Pestka S. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58 (1998) 2489-2499
54. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103 (2004) 3058-3064
55. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., and Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101 (1998) 746-754
56. Rothenfusser S., Hornung V., Ayyoub M., Britsch S., Towarowski A., Krug A., Sarris A., Lubenow N., Speiser D., Endres S., and Hartmann G. CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro. Blood 103 (2004) 2162-2169
57. Rothenfusser S., Hornung V., Krug A., Towarowski A., Krieg A.M., Endres S., and Hartmann G. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur. J. Immunol. 31 (2001) 3525-3534
58. Rothenfusser S., Tuma E., Wagner M., Endres S., and Hartmann G. Recent advances in immunostimulatory CpG oligonucleotides. Curr. Opin. Mol. Ther. 5 (2003) 98-106
59. Stewart V.A., McGrath S., Krieg A.M., Larson N.S., Angov E., Smith C.L., Brewer T.G., and Heppner Jr. D.G. Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques. Clin. Vac. Immunol. 15 (2008) 221-226
60. Teleshova N., Kenney J., Jones J., Marshall J., Van Nest G., Dufour J., Bohm R., Lifson J.D., Gettie A., and Pope M. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells. J. Immunol. 173 (2004) 1647-1657
61. Van der Stede Y., Cox E., Verdonck F., Vancaeneghem S., and Goddeeris B.M. Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha, 25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides. Vaccine 21 (2003) 1023-1032
62. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., and Goddeeris B.M. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet. Immunol. Immunopathol. 86 (2002) 31-41
63. Van der Stede Y., Verdonck F., Verfaillie T., Goddeeris B.M., and Cox E. Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes. Vet. Immunol. Immunopathol. 105 (2005) 115-124
64. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., and Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166 (2001) 2372-2377
65. Verthelyi D., Wang V.W., Lifson J.D., and Klinman D.M. CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques. Aids 18 (2004) 1003-1008
66. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34 (2004) 251-262
67. von Beust B.R., Johansen P., Smith K.A., Bot A., Storni T., and Kundig T.M. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur. J. Immunol. 35 (2005) 1869-1876
68. Wilson H.L., Dar A., Napper S.K., Marianela Lopez A., Babiuk L.A., and Mutwiri G.K. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides. Int. Rev. Immunol. 25 (2006) 183-213
69. Wu M., Gao R., Meng M., Li J., Tan M., Shen Y., Wang L., Yin X., Wu X., Xie H., and Liu S. Regulating effects of porcine interleukin-6 gene and CpG motifs on immune responses to porcine trivalent vaccines in mice. Res. Vet. Sci. 77 (2004) 49-57
70. Yi A.K., Klinman D.M., Martin T.L., Matson S., and Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157 (1996) 5394-5402